Advertisement
Singapore markets closed
  • Straits Times Index

    3,224.01
    -27.70 (-0.85%)
     
  • S&P 500

    5,252.92
    +4.43 (+0.08%)
     
  • Dow

    39,771.93
    +11.85 (+0.03%)
     
  • Nasdaq

    16,395.96
    -3.56 (-0.02%)
     
  • Bitcoin USD

    71,265.02
    +2,248.53 (+3.26%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,966.92
    +34.94 (+0.44%)
     
  • Gold

    2,233.80
    +21.10 (+0.95%)
     
  • Crude Oil

    82.47
    +1.12 (+1.38%)
     
  • 10-Yr Bond

    4.1910
    -0.0050 (-0.12%)
     
  • Nikkei

    40,168.07
    -594.66 (-1.46%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • FTSE Bursa Malaysia

    1,530.60
    -7.82 (-0.51%)
     
  • Jakarta Composite Index

    7,288.81
    -21.28 (-0.29%)
     
  • PSE Index

    6,903.53
    +5.36 (+0.08%)
     

Dow pops over 250 points, reclaims 26,000

Don’t call it a comeback. The Dow is surging over 250 points on its way to reclaiming 26,000. Plus, Apple’s going big, looking to spend $350 billion in the US. We break down the numbers. And check out bitcoin —breaking below $10,000. Now a major bank says look out below. Plus, earnings season for the biggest names is coming up. We preview the big reports everyone will be watching. Catch The Final Round at 3:55 ET p.m. with Jen Rogers, Yahoo Finance Editor-in-Chief Andy Serwer and Yahoo Finance markets correspondent Myles Udland.

Winners and losers

Stocks in the red today include GE dropping further as investors are still not convinced a breakup will fix all its problems; Ford as the automaker’s profit guidance missed the mark; and Goldman, with shares dropping as it’s the only bank of the 5 majors that reported revenue that declined from a year earlier. Goldman blamed the drop on its fixed-income trading division.

Stocks in the green today include Dick’s Sporting Goods as Buckingham Research upgraded the retailer to Buy with a new $42 price target; Juno Therapeutics as the Journal reports Celgene is in talks to buy the biotech company; and IBM, with shares up as Barclays upgraded it to Overweight, claiming Big Blue’s long revenue decline may soon end.

What’s next for tech and digital currencies?

David Garrity of GVA Research breaks down what’s next for bitcoin and big tech earnings.